In liver transplant recipients with the PM CYP2C19 genotype, lower doses of proton-pump inhibitors can be used to avoid drug intoxication in the treatment of peptic ulcer disease [6]. The gene discussed is CYP2C19; the disease is peptic ulcer disease.